Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 Apr;53(4):315–321. doi: 10.1136/thx.53.4.315

Brittle asthma

J Ayres 1, J Miles 1, P Barnes 1
PMCID: PMC1745199  PMID: 9741378

Full Text

The Full Text of this article is available as a PDF (123.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adcock I. M., Lane S. J., Brown C. R., Lee T. H., Barnes P. J. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med. 1995 Dec 1;182(6):1951–1958. doi: 10.1084/jem.182.6.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adcock I. M., Peters M., Gelder C., Shirasaki H., Brown C. R., Barnes P. J. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol. 1993 Aug;11(1):1–7. doi: 10.1677/jme.0.0110001. [DOI] [PubMed] [Google Scholar]
  3. Ayres J. G., Thompson R. A. Low IgG subclass levels in brittle asthma and in patients with exacerbations of asthma associated with respiratory infection. Respir Med. 1997 Sep;91(8):464–469. doi: 10.1016/s0954-6111(97)90111-6. [DOI] [PubMed] [Google Scholar]
  4. Ayres J. Continuous subcutaneous bronchodilators in brittle asthma. 1992 Apr 15-May 5Br J Hosp Med. 47(8):569–571. [PubMed] [Google Scholar]
  5. Ayres J., Fish D. R., Wheeler D. C., Wiggins J., Cochrane G. M., Skinner C. Subcutaneous terbutaline and control of brittle asthma or appreciable morning dipping. Br Med J (Clin Res Ed) 1984 Jun 9;288(6432):1715–1716. doi: 10.1136/bmj.288.6432.1715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barnes P. J., Adcock I. M. Steroid resistance in asthma. QJM. 1995 Jul;88(7):455–468. [PubMed] [Google Scholar]
  7. Barnes P. J. Blunted perception and death from asthma. N Engl J Med. 1994 May 12;330(19):1383–1384. doi: 10.1056/NEJM199405123301910. [DOI] [PubMed] [Google Scholar]
  8. Barnes P. J., Kharitonov S. A. Exhaled nitric oxide: a new lung function test. Thorax. 1996 Mar;51(3):233–237. doi: 10.1136/thx.51.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Barnes P. J. Poorly perceived asthma. Thorax. 1992 Jun;47(6):408–409. doi: 10.1136/thx.47.6.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Barnes P. J. Sensory nerves, neuropeptides, and asthma. Ann N Y Acad Sci. 1991;629:359–370. doi: 10.1111/j.1749-6632.1991.tb37989.x. [DOI] [PubMed] [Google Scholar]
  11. Bateman J. R., Clarke S. W. Sudden death in asthma. Thorax. 1979 Feb;34(1):40–44. doi: 10.1136/thx.34.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Beynon H. L., Garbett N. D., Barnes P. J. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet. 1988 Aug 13;2(8607):370–372. doi: 10.1016/s0140-6736(88)92837-1. [DOI] [PubMed] [Google Scholar]
  13. Bosley C. M., Fosbury J. A., Cochrane G. M. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J. 1995 Jun;8(6):899–904. [PubMed] [Google Scholar]
  14. Boulet L. P., Deschesnes F., Turcotte H., Gignac F. Near-fatal asthma: clinical and physiologic features, perception of bronchoconstriction, and psychologic profile. J Allergy Clin Immunol. 1991 Dec;88(6):838–846. doi: 10.1016/0091-6749(91)90239-k. [DOI] [PubMed] [Google Scholar]
  15. Carswell F. Thirty deaths from asthma. Arch Dis Child. 1985 Jan;60(1):25–28. doi: 10.1136/adc.60.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Clark T. J., Hetzel M. R. Diurnal variation of asthma. Br J Dis Chest. 1977 Apr;71(2):87–92. doi: 10.1016/0007-0971(77)90087-0. [DOI] [PubMed] [Google Scholar]
  17. Connolly C. K. Diurnal rhythms in airway obstruction. Br J Dis Chest. 1979 Oct;73(4):357–366. [PubMed] [Google Scholar]
  18. Coqueret O., Dugas B., Mencia-Huerta J. M., Braquet P. Regulation of IgE production from human mononuclear cells by beta 2-adrenoceptor agonists. Clin Exp Allergy. 1995 Apr;25(4):304–311. doi: 10.1111/j.1365-2222.1995.tb01047.x. [DOI] [PubMed] [Google Scholar]
  19. Corrigan C. J., Haczku A., Gemou-Engesaeth V., Doi S., Kikuchi Y., Takatsu K., Durham S. R., Kay A. B. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis. 1993 Mar;147(3):540–547. doi: 10.1164/ajrccm/147.3.540. [DOI] [PubMed] [Google Scholar]
  20. Crane J., Pearce N., Flatt A., Burgess C., Jackson R., Kwong T., Ball M., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet. 1989 Apr 29;1(8644):917–922. doi: 10.1016/s0140-6736(89)92505-1. [DOI] [PubMed] [Google Scholar]
  21. Djukanović R., Roche W. R., Wilson J. W., Beasley C. R., Twentyman O. P., Howarth R. H., Holgate S. T. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990 Aug;142(2):434–457. doi: 10.1164/ajrccm/142.2.434. [DOI] [PubMed] [Google Scholar]
  22. Ernst P., Habbick B., Suissa S., Hemmelgarn B., Cockcroft D., Buist A. S., Horwitz R. I., McNutt M., Spitzer W. O. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis. 1993 Jul;148(1):75–79. doi: 10.1164/ajrccm/148.1.75. [DOI] [PubMed] [Google Scholar]
  23. Garden G. M., Ayres J. G. Psychiatric and social aspects of brittle asthma. Thorax. 1993 May;48(5):501–505. doi: 10.1136/thx.48.5.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gardner R. M., Crapo R. O., Jackson B. R., Jensen R. L. Evaluation of accuracy and reproducibility of peak flowmeters at 1,400 m. Chest. 1992 Apr;101(4):948–952. doi: 10.1378/chest.101.4.948. [DOI] [PubMed] [Google Scholar]
  25. Garrett J., Kolbe J., Richards G., Whitlock T., Rea H. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax. 1995 Mar;50(3):303–311. doi: 10.1136/thx.50.3.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hyland M. E., Finnis S., Irvine S. H. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res. 1991;35(1):99–110. doi: 10.1016/0022-3999(91)90011-c. [DOI] [PubMed] [Google Scholar]
  27. Inman W. H., Adelstein A. M. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969 Aug 9;2(7615):279–285. doi: 10.1016/s0140-6736(69)90051-8. [DOI] [PubMed] [Google Scholar]
  28. Israel E., Rubin P., Kemp J. P., Grossman J., Pierson W., Siegel S. C., Tinkelman D., Murray J. J., Busse W., Segal A. T. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med. 1993 Dec 1;119(11):1059–1066. doi: 10.7326/0003-4819-119-11-199312010-00001. [DOI] [PubMed] [Google Scholar]
  29. Johnson A. J., Nunn A. J., Somner A. R., Stableforth D. E., Stewart C. J. Circumstances of death from asthma. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1870–1872. doi: 10.1136/bmj.288.6434.1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Keatings V. M., Collins P. D., Scott D. M., Barnes P. J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996 Feb;153(2):530–534. doi: 10.1164/ajrccm.153.2.8564092. [DOI] [PubMed] [Google Scholar]
  31. Kuwano K., Bosken C. H., Paré P. D., Bai T. R., Wiggs B. R., Hogg J. C. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993 Nov;148(5):1220–1225. doi: 10.1164/ajrccm/148.5.1220. [DOI] [PubMed] [Google Scholar]
  32. Lemanske R. F., Jr, Dick E. C., Swenson C. A., Vrtis R. F., Busse W. W. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest. 1989 Jan;83(1):1–10. doi: 10.1172/JCI113843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Leung D. Y., Martin R. J., Szefler S. J., Sher E. R., Ying S., Kay A. B., Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med. 1995 Jan 1;181(1):33–40. doi: 10.1084/jem.181.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lewis L. D., O'Driscoll B. R., Hartley R. B., Cochrane G. M. An unusual local reaction to continuous subcutaneous infused terbutaline in unstable asthmatics. Br J Dis Chest. 1987 Apr;81(2):189–193. doi: 10.1016/0007-0971(87)90139-2. [DOI] [PubMed] [Google Scholar]
  35. Lilly C. M., Bai T. R., Shore S. A., Hall A. E., Drazen J. M. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):548–553. doi: 10.1164/ajrccm.151.2.7531100. [DOI] [PubMed] [Google Scholar]
  36. Loza C., Brostoff J. Peanut allergy. Clin Exp Allergy. 1995 Jun;25(6):493–502. doi: 10.1111/j.1365-2222.1995.tb01086.x. [DOI] [PubMed] [Google Scholar]
  37. Miles J. F., Garden G. M., Tunnicliffe W. S., Cayton R. M., Ayres J. G. Psychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy. 1997 Oct;27(10):1151–1159. doi: 10.1046/j.1365-2222.1997.1080961.x. [DOI] [PubMed] [Google Scholar]
  38. Miles J., Cayton R., Ayres J. Atopic status in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy. 1995 Nov;25(11):1074–1082. doi: 10.1111/j.1365-2222.1995.tb03254.x. [DOI] [PubMed] [Google Scholar]
  39. Miller M. R., Dickinson S. A., Hitchings D. J. The accuracy of portable peak flow meters. Thorax. 1992 Nov;47(11):904–909. doi: 10.1136/thx.47.11.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Morton N. E. Major loci for atopy? Clin Exp Allergy. 1992 Dec;22(12):1041–1043. doi: 10.1111/j.1365-2222.1992.tb00126.x. [DOI] [PubMed] [Google Scholar]
  41. O'Driscoll B. R., Ruffles S. P., Ayres J. G., Cochrane G. M. Long term treatment of severe asthma with subcutaneous terbutaline. Br J Dis Chest. 1988 Oct;82(4):360–367. doi: 10.1016/0007-0971(88)90089-7. [DOI] [PubMed] [Google Scholar]
  42. O'Hollaren M. T., Yunginger J. W., Offord K. P., Somers M. J., O'Connell E. J., Ballard D. J., Sachs M. I. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991 Feb 7;324(6):359–363. doi: 10.1056/NEJM199102073240602. [DOI] [PubMed] [Google Scholar]
  43. Pearce N., Beasley R., Crane J., Burgess C., Jackson R. End of the New Zealand asthma mortality epidemic. Lancet. 1995 Jan 7;345(8941):41–44. doi: 10.1016/s0140-6736(95)91159-6. [DOI] [PubMed] [Google Scholar]
  44. Peters M. J., Adcock I. M., Brown C. R., Barnes P. J. Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol. 1995 Apr 28;289(2):275–281. doi: 10.1016/0922-4106(95)90104-3. [DOI] [PubMed] [Google Scholar]
  45. Picado C. Barcelona's asthma epidemics: clinical aspects and intriguing findings. Thorax. 1992 Mar;47(3):197–200. doi: 10.1136/thx.47.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25–29. doi: 10.1136/thx.47.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sears M. R., Beaglehole R. Asthma morbidity and mortality: New Zealand. J Allergy Clin Immunol. 1987 Sep;80(3 Pt 2):383–388. doi: 10.1016/0091-6749(87)90055-8. [DOI] [PubMed] [Google Scholar]
  48. Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sur S., Crotty T. B., Kephart G. M., Hyma B. A., Colby T. V., Reed C. E., Hunt L. W., Gleich G. J. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993 Sep;148(3):713–719. doi: 10.1164/ajrccm/148.3.713. [DOI] [PubMed] [Google Scholar]
  50. Sykes A. P., Lawson N., Finnegan J. A., Ayres J. G. Creatine kinase activity in patients with brittle asthma treated with long term subcutaneous terbutaline. Thorax. 1991 Aug;46(8):580–583. doi: 10.1136/thx.46.8.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Taylor A. J., Davies R. J., Hendrick D. J., Pepys J. Recurrent nocturnal asthmatic reactions to bronchial provocation tests. Clin Allergy. 1979 May;9(3):213–219. doi: 10.1111/j.1365-2222.1979.tb01544.x. [DOI] [PubMed] [Google Scholar]
  52. Taylor G. W., Taylor I., Black P., Maltby N. H., Turner N., Fuller R. W., Dollery C. T. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet. 1989 Mar 18;1(8638):584–588. doi: 10.1016/s0140-6736(89)91611-5. [DOI] [PubMed] [Google Scholar]
  53. Town G. I., Allan C. Ventilatory responses to hypoxia and hypercapnia in asthmatics with previous respiratory failure. Aust N Z J Med. 1989 Oct;19(5):426–430. doi: 10.1111/j.1445-5994.1989.tb00298.x. [DOI] [PubMed] [Google Scholar]
  54. Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest. 1977 Apr;71(2):73–86. doi: 10.1016/0007-0971(77)90086-9. [DOI] [PubMed] [Google Scholar]
  55. Ulrik C. S., Kok-Jensen A. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic. Eur Respir J. 1994 May;7(5):1003–1005. [PubMed] [Google Scholar]
  56. Virchow J. C., Jr, Hölscher U., Virchow C., Sr Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis. 1992 Sep;146(3):604–606. doi: 10.1164/ajrccm/146.3.604. [DOI] [PubMed] [Google Scholar]
  57. Wasserfallen J. B., Schaller M. D., Feihl F., Perret C. H. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis. 1990 Jul;142(1):108–111. doi: 10.1164/ajrccm/142.1.108. [DOI] [PubMed] [Google Scholar]
  58. Westerman D. E., Benatar S. R., Potgieter P. D., Ferguson A. D. Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus. Am J Med. 1979 Apr;66(4):565–572. doi: 10.1016/0002-9343(79)91165-3. [DOI] [PubMed] [Google Scholar]
  59. Wever A. M., Wever-Hess J., Hensgens H. E., Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations. Respir Med. 1994 Sep;88(8):613–621. doi: 10.1016/s0954-6111(05)80010-1. [DOI] [PubMed] [Google Scholar]
  60. Wong L. B., Miller I. F., Yeates D. B. Regulation of ciliary beat frequency by autonomic mechanisms: in vitro. J Appl Physiol (1985) 1988 Oct;65(4):1895–1901. doi: 10.1152/jappl.1988.65.4.1895. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES